Hiraoka M - Search Results

1

Early protective effect of bone marrow mononuclear cells against ischemic white matter damage through augmentation of cerebral blood flow.

Fujita Y, Ihara M, Ushiki T, Hirai H, Kizaka-Kondoh S, Hiraoka M, Ito H, Takahashi R. Fujita Y, et al. Among authors: hiraoka m. Stroke. 2010 Dec;41(12):2938-43. doi: 10.1161/STROKEAHA.110.596379. Epub 2010 Oct 14. Stroke. 2010. PMID: 20947840

2

Noninvasive tracking of donor cell homing by near-infrared fluorescence imaging shortly after bone marrow transplantation.

Ushiki T, Kizaka-Kondoh S, Ashihara E, Tanaka S, Masuko M, Hirai H, Kimura S, Aizawa Y, Maekawa T, Hiraoka M. Ushiki T, et al. Among authors: hiraoka m. PLoS One. 2010 Jun 14;5(6):e11114. doi: 10.1371/journal.pone.0011114. PLoS One. 2010. PMID: 20559437 Free PMC article.

3

In vivo imaging of brain ischemia using an oxygen-dependent degradative fusion protein probe.

Fujita Y, Kuchimaru T, Kadonosono T, Tanaka S, Hase Y, Tomimoto H, Hiraoka M, Kizaka-Kondoh S, Ihara M, Takahashi R. Fujita Y, et al. Among authors: hiraoka m. PLoS One. 2012;7(10):e48051. doi: 10.1371/journal.pone.0048051. Epub 2012 Oct 19. PLoS One. 2012. PMID: 23094105 Free PMC article.

4

Optical imaging of tumor hypoxia and evaluation of efficacy of a hypoxia-targeting drug in living animals.

Harada H, Kizaka-Kondoh S, Hiraoka M. Harada H, et al. Among authors: hiraoka m. Mol Imaging. 2005 Jul-Sep;4(3):182-93. doi: 10.1162/15353500200505112. Mol Imaging. 2005. PMID: 16194450

5

[Molecular imaging--diagnosis by functional imaging].

Kizaka-Kondoh S, Hiraoka M. Kizaka-Kondoh S, et al. Among authors: hiraoka m. Gan To Kagaku Ryoho. 2009 Mar;36(3):366-71. Gan To Kagaku Ryoho. 2009. PMID: 19295260 Japanese.

6

In vivo imaging of HIF-active tumors by an oxygen-dependent degradation protein probe with an interchangeable labeling system.

Kuchimaru T, Kadonosono T, Tanaka S, Ushiki T, Hiraoka M, Kizaka-Kondoh S. Kuchimaru T, et al. Among authors: hiraoka m. PLoS One. 2010 Dec 23;5(12):e15736. doi: 10.1371/journal.pone.0015736. PLoS One. 2010. PMID: 21203417 Free PMC article.

7

Antitumor protein therapy; application of the protein transduction domain to the development of a protein drug for cancer treatment.

Harada H, Kizaka-Kondoh S, Hiraoka M. Harada H, et al. Among authors: hiraoka m. Breast Cancer. 2006;13(1):16-26. doi: 10.2325/jbcs.13.16. Breast Cancer. 2006. PMID: 16518058 Free article. Review.

8

TS-1 enhances the effect of radiotherapy by suppressing radiation-induced hypoxia-inducible factor-1 activation and inducing endothelial cell apoptosis.

Zeng L, Ou G, Itasaka S, Harada H, Xie X, Shibuya K, Kizaka-Kondoh S, Morinibu A, Shinomiya K, Hiraoka M. Zeng L, et al. Among authors: hiraoka m. Cancer Sci. 2008 Nov;99(11):2327-35. doi: 10.1111/j.1349-7006.2008.00943.x. Epub 2008 Sep 22. Cancer Sci. 2008. PMID: 18823375 Free PMC article.

9

The Akt/mTOR pathway assures the synthesis of HIF-1alpha protein in a glucose- and reoxygenation-dependent manner in irradiated tumors.

Harada H, Itasaka S, Kizaka-Kondoh S, Shibuya K, Morinibu A, Shinomiya K, Hiraoka M. Harada H, et al. Among authors: hiraoka m. J Biol Chem. 2009 Feb 20;284(8):5332-42. doi: 10.1074/jbc.M806653200. Epub 2008 Dec 19. J Biol Chem. 2009. PMID: 19098000 Free article.

10

The HIF-1-active microenvironment: an environmental target for cancer therapy.

Kizaka-Kondoh S, Tanaka S, Harada H, Hiraoka M. Kizaka-Kondoh S, et al. Among authors: hiraoka m. Adv Drug Deliv Rev. 2009 Jul 2;61(7-8):623-32. doi: 10.1016/j.addr.2009.01.006. Epub 2009 May 3. Adv Drug Deliv Rev. 2009. PMID: 19409433 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,278 results

Search Page

Filters